Table 3.
Number and rates of new pulmonary metastatic events by grade across standard surveillance time intervals*
Sarcoma grade | Years posttreatment | New lung metastasis events/patient-year | Number of patients needed to screen to detect 1 new metastatic event/year | Proposed screening frequency |
---|---|---|---|---|
Low | 0–5 | 0.023 | 44 | 12 months |
5–10 | 0 | - | None | |
> 10 | 0 | - | None | |
Int. | 0–2 | 0.52 | 2 | 3 months |
2–5 | 0.029 | 35 | 12 months | |
5–10 | 0.026 | 39 | 12 months | |
> 10 | 0.0038 | 264 | None | |
High | 0–2 | 0.66 | 2 | 3 months |
2–5 | 0.11 | 10 | 6 months | |
5–10 | 0.018 | 56 | 12 months | |
> 10 | 0.0012 | 834 | None |
* The number of patients needed to be screened to detect one patient with new metastasis per year is listed.